FreshRecalls

⚠ Data freshness notice: the most recent refresh of NHTSA was incomplete, so a very recent recall may be missing. Everything shown is accurate as of the last checked time on this page — for anything time-critical, confirm with the official sources linked below.

FDAClass I · Drug · Recalled May 27, 2026

MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%) recall — Wisconsin Pharmacal Company

Hazard: Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.

Class I: most serious — reasonable probability of serious health consequences or death.

View the official FDA enforcement record (openFDA) ↗

Official recall ID
D-0553-2026
Brand
Wisconsin Pharmacal Company
Classification
Class I
Units affected
690 tubes
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Description

MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.

Affected products

Companies & origin

Recalling firm location
Jackson, WI, United States
Firm address
N168w22223 Main St, 53037

Identifying details (verbatim from the notice)

Product codes / lots
Lot #: 1024088, Exp 11/30/2026
Distribution
USA Nationwide and Bahamas
Firm notified the public via
Letter
FDA event ID
98788
Recall initiated
April 24, 2026
FDA classified
May 29, 2026
FDA report date
May 27, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 23, 2026 at 11:04 PM UTC.

Report a data error on this page